过去 90 天内没有内部人买入。最近一笔由 Erceg Mark J 披露于 2021年3月10日。
CERNER Corp：高管交易动态
成立于1979年的CERNER Corp归属医疗与制药行业。公司董事和高级管理人员通过SEC (Form 4)申报交易。过去一年很平静：CERNER Corp没有一份高管申报。上一份申报发布于2022年6月9日。
我们关于CERNER Corp的记录可追溯至2006年，累计有19笔买入和808笔卖出。
数据来源：高管申报（SEC (Form 4)）。过往交易不代表未来收益。
该评分只在所属市场内对买入进行排名。仅在经过回测的策略范围内的交易所提供建议仓位；其他市场的信号仍处于观察状态。并非投资建议。
财务数据
财年 2021财年截至 2021年12月 · cache
- 37 股@ US$95.000.1% 占其流量股票SEC:0001209191-22-035500:1
- 454 股@ US$95.000.8% 占其流量股票SEC:0001209191-22-035488:1
- 19,188 股@ US$95.0032.1% 占其流量股票SEC:0001209191-22-035488:2
- 3,188 股@ US$95.0011.8% 占其流量股票SEC:0001209191-22-035508:1
- 12,421 股@ US$95.0046.2% 占其流量股票SEC:0001209191-22-035508:2
- 3,680 股@ US$95.006.2% 占其流量股票SEC:0001209191-22-035504:1
- 926 股@ US$95.000.9% 占其流量股票SEC:0001209191-22-035492:1
- 8,910 股@ US$95.008.2% 占其流量股票SEC:0001209191-22-035492:2
- 5,403 股@ US$95.0066.1% 占其流量股票SEC:0001209191-22-035498:1
- 154 股@ US$95.000.5% 占其流量股票SEC:0001209191-22-035502:1
- 3,412 股@ US$95.003.4% 占其流量股票SEC:0001209191-22-035484:1
- 332 股@ US$95.000.5% 占其流量股票SEC:0001209191-22-035493:2
- 7 股@ US$95.000.0% 占其流量股票SEC:0001209191-22-035493:1
- 6,246 股@ US$95.00100.0% 占其流量股票SEC:0001209191-22-035508:0
- 371 股@ US$95.008.2% 占其流量股票SEC:0001209191-22-035484:0
- 23,438 股@ US$95.00100.0% 占其流量股票SEC:0001209191-22-035499:0
- 12,825 股@ US$95.00100.0% 占其流量股票SEC:0001209191-22-035503:0
- 26,588 股@ US$95.00100.0% 占其流量股票SEC:0001209191-22-035504:0
- 21,909 股@ US$95.00100.0% 占其流量股票SEC:0001209191-22-035500:0
- 2,768 股@ US$95.00100.0% 占其流量股票SEC:0001209191-22-035498:0
- 844 股@ US$95.005.3% 占其流量股票SEC:0001209191-22-035502:0
- 539 股@ US$95.0015.5% 占其流量股票SEC:0001209191-22-035488:0
- 37,460 股@ US$95.00100.0% 占其流量股票SEC:0001209191-22-035491:0
- 43,905 股@ US$95.00100.0% 占其流量股票SEC:0001209191-22-035493:0
- 295 股@ US$95.002.2% 占其流量股票SEC:0001209191-22-035492:0
1590 条申报中的 25 条
About CERNER Corp
Recent developments are dominated by post-acquisition integration rather than standalone corporate actions. Oracle has been repositioning the Cerner asset base under the Oracle Health banner, with a focus on cloud modernization, AI-enabled clinical tools, and tighter integration with Oracle’s broader data and application stack. In practical terms, that means Cerner’s former strategic themes—EHR modernization, workflow automation, interoperability, and hospital digitization—now sit inside Oracle’s healthcare strategy rather than a separate public company. As a result, SEC Form 4 insider-trading activity is associated with Oracle, not Cerner as an independent issuer. For French, Belgian, and Swiss investors, Cerner is best viewed as a historically important U.S. healthcare software franchise that has been folded into a much larger NASDAQ-listed parent, rather than as a separately traded stock.
